Chronic Headaches Clinical Trial
Official title:
Additive Effects of Aerobic Exercise to a Standard Behavioral Self-Management Program for Chronic Headaches
This proposed study seeks to examine whether adding an aerobic exercise prescription to a behavioral treatment program for chronic headaches will improve headache frequency and intensity, headache-related disability, and mood. It is hypothesized that participants who receive the exercise prescription at the start of treatment will show greater gains than those who receive the prescription halfway through treatment. It is also predicted that participants who begin the exercise component halfway through treatment will demonstrate greater improvement in the second half of treatment compared to the first half.
Status | Completed |
Enrollment | 5 |
Est. completion date | August 2012 |
Est. primary completion date | June 2012 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 64 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of chronic headache (according to International Headache Association (IHA) guidelines) by research personnel - Interested in receiving behavioral treatment for chronic headaches - Engaged in less than 60 minutes/week of physical activity in the past 3 months - Physically capable of engaging in a regular exercise routine - Interested in in taking part in a regular exercise routine - Regular internet access (at least once a week) Exclusion Criteria: - Males - Unable to access internet at least once a week - Currently engaging in regular exercise - Not interested in participating in regular exercise - Not capable of safely exercising - Pregnant, nursing, or planning on becoming pregnant during the course of the study - Does not meet IHA diagnostic criteria for chronic headache - Not interested in behavioral headache treatment - Diagnosis of Medication Overuse Headache, or headaches related to a physical or neurological disorder - Cognitive or other forms of impairment that would decrease ability to fully engage in treatment |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | University of Mississippi Medical Center | Jackson | Mississippi |
Lead Sponsor | Collaborator |
---|---|
University of Mississippi Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patient-reported headache-free days per week | Patients are asked to report the number of days per week they do no experience headaches | 2 weeks prior to treatment through 2 weeks post-treatment | No |
Secondary | Headache Disability Index (HDI) | HDI is a 25-item questionnaire that assesses headache-related functional and emotional disability in chronic headache sufferers. Participants respond to items using a 3-point scale: "yes," "sometimes," or "no." | baseline, 8 weeks, 10 weeks | No |
Secondary | Highest weekly headache intensity | Patients are asked to report the the intensity of their worst headache during the past week, using a 0 (pain-free) to 10 (extremely intense pain) scale. | 2 weeks prior to treatment through 2 weeks post-treatment | No |
Secondary | Composite Depression/Anxiety Screening Scale (PHQ-4) | This is a 4-item measure assessing symptoms of anxiety and depression in the past two weeks. Participants respond on a 4 point scale: 0=Not at all; 1=Several days; 2=More than half of the days; 3=Nearly every day. When this measure is administered during the course of treatment (weekly) participants will be asked to respond based on their experiences in the past week. | 2 weeks prior to treatment through 2 weeks follow-up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00205829 -
Bion for Occipital Nerve Stimulation
|
Phase 1/Phase 2 | |
Completed |
NCT00269581 -
Headstrong Intervention for Pediatric Headache
|
Phase 3 |